← Back to Clinical Trials
Recruiting NCT07461818

Point of Care - Triage and Treatment for Cervical Pre-cancer

Trial Parameters

Condition Cervical Precancer
Sponsor Basic Health International, Inc.
Study Type INTERVENTIONAL
Phase N/A
Enrollment 5,000
Sex FEMALE
Min Age 30 Years
Max Age 49 Years
Start Date 2026-03
Completion 2029-01
Interventions
IRIS™ Thermal Ablation Device

Brief Summary

This study evaluates a modified two-probe thermal ablation protocol using the IRIS™ device and retrospectively assesses an AI-based Automated Visual Evaluation (AVE) triage algorithm among HPV-positive women in El Salvador. The primary objective is to estimate 1-year cure rates of CIN2+ following treatment. A secondary objective is to evaluate the diagnostic performance of AVE compared with histopathology.

Eligibility Criteria

Inclusion Criteria: * Women aged 30-49 years * Non-pregnant (determined by urine pregnancy test) * HPV-positive per Ministry of Health (MOH) records * Willing to undergo colposcopy and biopsies * Able and willing to provide informed consent Exclusion Criteria: * Plans to become pregnant during the study * History of LEEP or cervical ablation procedure in the past 5 years * History of total hysterectomy (verified by medical record or pelvic evaluation) * History of cervical cancer * Unable or unwilling to provide a permanent and reliable address * Unable or unwilling to provide informed consent

Related Trials